Commentary: Intestinal barrier function and immune homeostasis are missing links in obesity and type 2 diabetes development

Yi-Feng Wang^{1

2}, Song Wang¹, Hong-Yang Xu¹, Li-Jun Liu²

Affiliations

¹ Department of Critical Care Medicine, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, China.
² Department of Emergency and Critical Care Medicine, Second Affiliated Hospital of Soochow University, Suzhou, China.

Comment

Yi-Feng Wang et al. Front Endocrinol (Lausanne). 2022.

. 2022 Aug 10:13:939703.

doi: 10.3389/fendo.2022.939703. eCollection 2022.

Yi-Feng Wang^{1

2}, Song Wang¹, Hong-Yang Xu¹, Li-Jun Liu²

¹ Department of Critical Care Medicine, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, China.
² Department of Emergency and Critical Care Medicine, Second Affiliated Hospital of Soochow University, Suzhou, China.

No abstract available

Keywords: crosstalk; hyperglycemia; intestinal barrier dysfunction; stress-induced hyperglycemia; type 2 diabetes.

Comment on

Intestinal Barrier Function and Immune Homeostasis Are Missing Links in Obesity and Type 2 Diabetes Development.
Riedel S, Pheiffer C, Johnson R, Louw J, Muller CJF. Riedel S, et al. Front Endocrinol (Lausanne). 2022 Jan 25;12:833544. doi: 10.3389/fendo.2021.833544. eCollection 2021. Front Endocrinol (Lausanne). 2022. PMID: 35145486 Free PMC article. Review.

1. Riedel S, Pheiffer C, Johnson R, Louw J, Muller CJF. Intestinal barrier function and immune homeostasis are missing links in obesity and type 2 diabetes development. Front Endocrinol (2021) 12:833544. doi: 10.3389/fendo.2021.833544 - DOI - PMC - PubMed
1. Massier L, Blüher M, Kovacs P, Chakaroun RM. Impaired intestinal barrier and tissue bacteria: Pathomechanisms for metabolic diseases. Front Endocrinol (2021) 12:616506. doi: 10.3389/fendo.2021.616506 - DOI - PMC - PubMed
1. Thaiss CA, Levy M, Grosheva I, Zheng D, Soffer E, Blacher E, et al. Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection. Science (2018) 359(6382):1376–83. doi: 10.1126/science.aar3318 - DOI - PubMed
1. Wang Y, Ding L, Yang J, Liu L, Dong L. Intestinal fatty acid-binding protein, a biomarker of intestinal barrier dysfunction, increases with the progression of type 2 diabetes. PeerJ (2021) 9:e10800. doi: 10.7717/peerj.10800 - DOI - PMC - PubMed
1. Klingensmith NJ, Coopersmith CM. The gut as the motor of multiple organ dysfunction in critical illness. Crit Care Clin (2016) 32(2):203. doi: 10.1016/j.ccc.2015.11.004 - DOI - PMC - PubMed